Netherlands Pharmaceutical Market Share

Statistics for the 2023 & 2024 Netherlands Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Netherlands Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Netherlands Pharmaceutical Industry

The Dutch pharmaceutical market is moderately fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies which are currently dominating the market are Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma, AstraZeneca PLC, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, and Pfizer Inc.

Netherlands Pharmaceutical Market Leaders

  1. Abbott Laboratories

  2. AbbVie Inc.

  3. AstraZeneca Plc

  4. Novartis AG

  5. F. Hoffmann-La Roche AG

*Disclaimer: Major Players sorted in no particular order

Picture36.png

Netherlands Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)